Teprotumumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Teprotumumab and local guidelines before prescribing.

IGF-1R antibody

Mechanism

IGF-1 receptor monoclonal antibody.

Uses

Thyroid eye disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hearing loss, hyperglycaemia, muscle spasms.

Interactions

Few.

Contraindications and cautions

Pregnancy

Monitoring

Hearing, glucose

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Baseline audiology and glucose.

More from the textbook: uses, cautions and other points
Where it is discussed in the book